Live Breaking News & Updates on Krys Tal Griffin|Page 4
Stay updated with breaking news from Krys tal griffin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report)’s share price traded down 3.2% during trading on Thursday . The company traded as low as $119.42 and last traded at $119.45. 261,845 shares traded hands during trading, an increase of 4% from the average session volume of 252,661 shares. The stock had previously closed at $123.40. […] ....
Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) insider Suma Krishnan sold 25,000 shares of Krystal Biotech stock in a transaction on Monday, September 11th. The stock was sold at an average price of $127.23, for a total transaction of $3,180,750.00. Following the sale, the insider now owns 1,599,206 shares of the company’s stock, valued […] ....
Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) saw a large decline in short interest during the month of July. As of July 31st, there was short interest totalling 1,330,000 shares, a decline of 7.6% from the July 15th total of 1,440,000 shares. Based on an average daily trading volume, of 324,300 shares, the short-interest […] ....
Krystal Biotech (NASDAQ:KRYS – Free Report) had its price target lifted by Chardan Capital from $148.00 to $153.00 in a research note released on Monday, Marketbeat.com reports. They currently have a buy rating on the stock. Chardan Capital also issued estimates for Krystal Biotech’s FY2023 earnings at ($5.22) EPS and FY2024 earnings at $2.75 EPS. […] ....
HC Wainwright reiterated their buy rating on shares of Krystal Biotech (NASDAQ:KRYS – Free Report) in a research report report published on Monday morning, Benzinga reports. The brokerage currently has a $139.00 price objective on the stock. Several other research analysts have also recently issued reports on the stock. Stifel Nicolaus increased their target price […] ....